Efficacy of Nitazoxanide Alone or Loaded with Silica Nanoparticle for Treatment of Cryptosporidiosis in Immunocompetent Hosts

Background: Cryptosporidiosis is a major health problem for humans and animals with severe consequences in immune deficient hosts. There is no effective approved drug therapy against Cryptosporidium till now and it is increasingly necessary for evaluating new potential drugs. Nanoparticles are promi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Alaa Metawae, Ahmed Bayoumy, Ibrahim Ali, Olfat Hammam, Khaled A. Temsah A. Temsah
Formato:	article
Lenguaje:	EN
Publicado:	Al-Azhar University, Faculty of Medicine (Damietta) 2021
Materias:	cryptosporidium nitazoxanide silica nanoparticles parasitic diarrhea Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/24ac494f0486481283ba12b7df5d5496
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:24ac494f0486481283ba12b7df5d5496
record_format	dspace
spelling	oai:doaj.org-article:24ac494f0486481283ba12b7df5d54962021-12-02T14:44:39ZEfficacy of Nitazoxanide Alone or Loaded with Silica Nanoparticle for Treatment of Cryptosporidiosis in Immunocompetent Hosts2636-41742682-378010.21608/ijma.2021.55788.1237https://doaj.org/article/24ac494f0486481283ba12b7df5d54962021-04-01T00:00:00Zhttps://ijma.journals.ekb.eg/article_150867_d7a116d24426ef7abce502cdedc3dab0.pdfhttps://doaj.org/toc/2636-4174https://doaj.org/toc/2682-3780Background: Cryptosporidiosis is a major health problem for humans and animals with severe consequences in immune deficient hosts. There is no effective approved drug therapy against Cryptosporidium till now and it is increasingly necessary for evaluating new potential drugs. Nanoparticles are promising for effective treatment of parasitic diseases, as an emerging drug carriers. The aim of the work: Studying nitazoxanide efficacy alone and compared to nitazoxanide loaded with silica nanoparticles in the treatment of cryptosporidiosis in immunocompetent mice infected with Cryptosporidium. Materials and methods: The study included 50 Swiss albino mice subdivided into five subgroups, including treatment either with silica nanoparticles alone, with Nitazoxanide alone or by Nitazoxanide loaded with silica nanoparticles. We included infected non-treated and non- infected non treated mice in the study as the positive and the negative controls, respectively. The post-treatment evaluation at two and three weeks was done using parasitological stool examination, histological examination of the intestine and liver, and serological screening for anti-cryptosporidium IgG and IgM using ELISA at the 3rd week only. Results: Decreased percentages of cryptosporidium oocyst passage in all treated immunocompetent mice groups and an improvement on the intestinal and liver histopathology observed after two weeks and a significant oocyst count reduction and near total histopathological cure observed after the third week with superior results observed in groups treated with Nitazoxanide loaded silica. Conclusion: Cryptosporidium infection is a potentially harmful condition. Major histopathological changes and clinical deterioration occur in immunocompromized hosts requiring more available therapeutic options. The nitazoxanide loaded silica showed promising results in the treated groups superior to nitazoxanide alone. This gives promising results encouraging further evaluation studies.Alaa MetawaeAhmed BayoumyIbrahim AliOlfat HammamKhaled A. Temsah A. TemsahAl-Azhar University, Faculty of Medicine (Damietta)articlecryptosporidiumnitazoxanidesilicananoparticlesparasitic diarrheaMedicine (General)R5-920ENInternational Journal of Medical Arts, Vol 3, Iss 2, Pp 1229-1239 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	cryptosporidium nitazoxanide silica nanoparticles parasitic diarrhea Medicine (General) R5-920
spellingShingle	cryptosporidium nitazoxanide silica nanoparticles parasitic diarrhea Medicine (General) R5-920 Alaa Metawae Ahmed Bayoumy Ibrahim Ali Olfat Hammam Khaled A. Temsah A. Temsah Efficacy of Nitazoxanide Alone or Loaded with Silica Nanoparticle for Treatment of Cryptosporidiosis in Immunocompetent Hosts
description	Background: Cryptosporidiosis is a major health problem for humans and animals with severe consequences in immune deficient hosts. There is no effective approved drug therapy against Cryptosporidium till now and it is increasingly necessary for evaluating new potential drugs. Nanoparticles are promising for effective treatment of parasitic diseases, as an emerging drug carriers. The aim of the work: Studying nitazoxanide efficacy alone and compared to nitazoxanide loaded with silica nanoparticles in the treatment of cryptosporidiosis in immunocompetent mice infected with Cryptosporidium. Materials and methods: The study included 50 Swiss albino mice subdivided into five subgroups, including treatment either with silica nanoparticles alone, with Nitazoxanide alone or by Nitazoxanide loaded with silica nanoparticles. We included infected non-treated and non- infected non treated mice in the study as the positive and the negative controls, respectively. The post-treatment evaluation at two and three weeks was done using parasitological stool examination, histological examination of the intestine and liver, and serological screening for anti-cryptosporidium IgG and IgM using ELISA at the 3rd week only. Results: Decreased percentages of cryptosporidium oocyst passage in all treated immunocompetent mice groups and an improvement on the intestinal and liver histopathology observed after two weeks and a significant oocyst count reduction and near total histopathological cure observed after the third week with superior results observed in groups treated with Nitazoxanide loaded silica. Conclusion: Cryptosporidium infection is a potentially harmful condition. Major histopathological changes and clinical deterioration occur in immunocompromized hosts requiring more available therapeutic options. The nitazoxanide loaded silica showed promising results in the treated groups superior to nitazoxanide alone. This gives promising results encouraging further evaluation studies.
format	article
author	Alaa Metawae Ahmed Bayoumy Ibrahim Ali Olfat Hammam Khaled A. Temsah A. Temsah
author_facet	Alaa Metawae Ahmed Bayoumy Ibrahim Ali Olfat Hammam Khaled A. Temsah A. Temsah
author_sort	Alaa Metawae
title	Efficacy of Nitazoxanide Alone or Loaded with Silica Nanoparticle for Treatment of Cryptosporidiosis in Immunocompetent Hosts
title_short	Efficacy of Nitazoxanide Alone or Loaded with Silica Nanoparticle for Treatment of Cryptosporidiosis in Immunocompetent Hosts
title_full	Efficacy of Nitazoxanide Alone or Loaded with Silica Nanoparticle for Treatment of Cryptosporidiosis in Immunocompetent Hosts
title_fullStr	Efficacy of Nitazoxanide Alone or Loaded with Silica Nanoparticle for Treatment of Cryptosporidiosis in Immunocompetent Hosts
title_full_unstemmed	Efficacy of Nitazoxanide Alone or Loaded with Silica Nanoparticle for Treatment of Cryptosporidiosis in Immunocompetent Hosts
title_sort	efficacy of nitazoxanide alone or loaded with silica nanoparticle for treatment of cryptosporidiosis in immunocompetent hosts
publisher	Al-Azhar University, Faculty of Medicine (Damietta)
publishDate	2021
url	https://doaj.org/article/24ac494f0486481283ba12b7df5d5496
work_keys_str_mv	AT alaametawae efficacyofnitazoxanidealoneorloadedwithsilicananoparticlefortreatmentofcryptosporidiosisinimmunocompetenthosts AT ahmedbayoumy efficacyofnitazoxanidealoneorloadedwithsilicananoparticlefortreatmentofcryptosporidiosisinimmunocompetenthosts AT ibrahimali efficacyofnitazoxanidealoneorloadedwithsilicananoparticlefortreatmentofcryptosporidiosisinimmunocompetenthosts AT olfathammam efficacyofnitazoxanidealoneorloadedwithsilicananoparticlefortreatmentofcryptosporidiosisinimmunocompetenthosts AT khaledatemsahatemsah efficacyofnitazoxanidealoneorloadedwithsilicananoparticlefortreatmentofcryptosporidiosisinimmunocompetenthosts
_version_	1718389555294371840

Efficacy of Nitazoxanide Alone or Loaded with Silica Nanoparticle for Treatment of Cryptosporidiosis in Immunocompetent Hosts

Ejemplares similares